ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Total Liabilities
Everything the company owes to creditors and other parties.
No reported Total Liabilities figures are available to summarize.
Total Liabilities history
Currency unavailable · from the balance sheet
No Total Liabilities data reported for this period type.
Total Liabilities vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $302.79M USD | +58.6% | +7.7% | 123.8% | |
| Mar 2026 | $218.03M USD | -1.5% | +71.4% | 74.0% | |
| Mar 2026 | $71.81M USD | -38.4% | -16.3% | 12.3% | |
| Mar 2026 | $65.72M USD | -77.9% | -6.8% | 57.1% | |
| Mar 2026 | €61.5M EUR | -21.7% | -15.4% | 62.0% | |
| Mar 2026 | $58.26M USD | — | — | 19.9% | |
| Mar 2026 | $54.05M USD | -44.9% | -31.8% | 22.0% | |
| Mar 2026 | $48.4M USD | -14.8% | -2.5% | 10.9% | |
| Mar 2026 | $3.67M USD | -52.0% | -9.4% | 2.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -30.1% | -8.1% | 22.0% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.